Liver Cancer Imaging and Tumor Study
Part of Cancer, Digestive system clinical trials.
This study looks at how liver cancer appears on CT or MRI scans and how it connects with the tumor's biology. It aims to find better ways to understand and treat liver cancer by linking imaging features with the tumor environment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are being treated for liver cancer at Wuhan Union Hospital.
- You are older than 18 years old.
- You had at least one CT or MRI scan before starting treatment.
- A tissue biopsy confirmed your diagnosis of liver cancer.
- Your medical records and follow-up information are complete.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is creating a database of people with liver cancer (including hepatocellular carcinoma and other types). It aims to collect health information and samples over time to better understand the disease and improve future care. If you join, you will be asked to provide blood and leftover tissue from surgery or biopsy, and to follow up with the research team.
This trial looks at whether special features seen on contrast-enhanced ultrasound can help doctors better classify liver nodules using a system called LI-RADS. It’s for people at high risk for liver cancer who have recent imaging and clear tissue diagnosis.
This study looks at how CT scans of lung cancer can be linked to the tumor's biology and genetics. It aims to understand lung cancer better by combining imaging with lab results.
This study looks at how scans (CT or MRI) can help doctors understand the environment around urologic tumors. It may lead to better ways to predict treatment response and outcomes.
This study builds a database of information from liver cancer patients treated at Tongji Hospital. Researchers will collect your medical records and treatment information to better understand liver cancer diagnosis and care over time.
This study uses artificial intelligence (AI) to analyze your CT or MRI scans and help predict how well immunotherapy might work for your liver cancer. The goal is to find better ways to match you with the right treatment and improve your outcomes.
Hear when a new Liver Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.